ArticleOncoimmunology2012
A genetic inference on cancer immune responsiveness.
Article in Oncoimmunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- The dark matter in cancer immunology: beyond the visible- unveiling multiomics pathways to breakthrough therapies.Journal of translational medicine · 2025Review
- Turkish Validation and Reliability of the EORTC QLQ-CR29 Quality of Life Scale for Colorectal Cancer.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021Article
- How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers.Frontiers in oncology · 2021Review
- Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors.Frontiers in immunology · 2020Review
- The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier.Cancer treatment and research · 2020Article
- Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients.Cancers · 2019Article
- Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.Journal for immunotherapy of cancer · 2019Review
- Immune oncology, immune responsiveness and the theory of everything.Journal for immunotherapy of cancer · 2018Article
- The influence of diet on anti-cancer immune responsiveness.Journal of translational medicine · 2018Review
- The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy.Emerging topics in life sciences · 2017Article
- Cancer immune resistance: can theories converge?Emerging topics in life sciences · 2017Article
- Tumor-intrinsic oncogene pathways mediating immune avoidance.Oncoimmunology · 2016Review
- Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy.Frontiers in oncology · 2015Review
- The immune-related role of BRAF in melanoma.Molecular oncology · 2015Article
- Melanoma NOS1 expression promotes dysfunctional IFN signaling.The Journal of clinical investigation · 2014Article
- Personalizing health care: feasibility and future implications.BMC medicine · 2013Review
- IRF5 gene polymorphisms in melanoma.Journal of translational medicine · 2012Article
- Reflections upon human cancer immune responsiveness to T cell-based therapy.Cancer immunology, immunotherapy : CII · 2012Review
- Radiation as an immunological adjuvant: current evidence on dose and fractionation.Frontiers in oncology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A cancer immune signature implicating good prognosis and responsiveness to immunotherapy was described that is observed also in other aspects of immune-mediated, tissue-specific destruction (TSD). Its determinism remains, however, elusive. Based on limited but unique clinical observations, we propose a multifactorial genetic model of human cancer immune responsiveness.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.